|
BMRN | Biomarin Pharmaceutical Inc |
|
|
BMRN | Biomarin Pharmaceutical Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.40 |
| Leverage | 19.01% |
| Market Cap | $ 12.2B |
| PE | 23.42 |
| Dividend Yield | 0.00% |
| Profit | $ 522.5m |
| Margin | 17.76% |
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.